Assisted Reproduction Registries and Reporting

Assisted Reproductive Technology in Australia and New Zealand 2014

Harris K, Fitzgerald O, Paul RC, Macaldowie A, Lee E, Chambers GM

National Perinatal Epidemiology and Statistics Unit, 2016
DOI 10.26190/unsworks/30470

RRM Academy Synopsis

18.2% of Australian and New Zealand ART cycles ended in live delivery

A 2014 report on all fertility clinics in Australia and New Zealand finds that about 18 out of 100 ART treatment cycles ended in a live delivery. In women's own fresh and thaw cycles, live deliveries per embryo transfer declined with age. Multiple deliveries became less common as single embryo transfer grew.

Study at a glance, annual registry summary: 18.2% of ART cycles in Australia and New Zealand ended in live delivery
Study at a glance, annual registry summary of 73,598 ART treatment cycles: 18.2% of ART cycles in Australia and New Zealand ended in live delivery. Source: Harris K et al., 2016, DOI 10.26190/unsworks/30470.

Key Findings

  • Of 73,598 ART treatment cycles started in 2014, 23.7% (17,427) led to a clinical pregnancy and 18.2% (13,373) to a live delivery.
  • In autologous fresh cycles, live delivery per embryo transfer was 38.7% for women under 30, 9.9% at ages 40 to 44, and 1.2% at 45 or older.
  • Among 15,055 women who began a first autologous fresh cycle in 2012, the cycle-specific live delivery rate was 22.8% in the first cycle and 9.2% in the eighth.
  • Multiple deliveries fell from 7.9% in 2010 to 4.9% in 2014, while single embryo transfer reached 82.9% of embryo transfer cycles.
  • After embryo transfer cycles in 2014, 16.1% of babies were preterm and 49.4% of deliveries were caesarean, against 8.6% and 33.0% for all of Australia in 2013.

Interpretation

The report is an annual registry summary of treatment cycles from clinics in both countries. Outcomes are counted for each cycle, and the report notes that some individuals may appear more than once. Perinatal outcomes are compared with national birth statistics for Australia in 2013, and no untreated comparison group appears. The registry does not collect the reasons women do not return for further cycles, such as spontaneous pregnancy, so the rates describe outcomes only. The authors note that the 2012 cohort rates may change as women return for later cycles. They also note that the higher caesarean rate may relate to older maternal age and more multiple births.

RRM Context

The registry lists 22.3% of initiated cycles as unexplained infertility and 19.7% as male factor only. Restorative reproductive medicine treats unexplained infertility as undiagnosed and examines both partners for the cause. In the unexplained group, ART proceeds without establishing why conception fails. The registry counts the treatments and results while that diagnosis stays open.

Key figures

Treatment activity, 2014

Measure Value Source
Total ART treatment cycles reported, Australia and New Zealand, 2014 73,598 Summary
ART treatment cycles conducted in Australia, 2014 67,707 Summary
ART treatment cycles conducted in New Zealand, 2014 5,891 Summary
Autologous (own oocyte or embryo) cycles as a share of all ART treatments, 2014 94.6% Summary
Frozen-thawed embryo cycles as a share of autologous cycles, 2014 37.4% Summary

Pregnancy and birth outcomes, 2014

Measure Value Source
Clinical pregnancy rate for initiated ART cycles, 2014 23.7% (17,427) Treatment outcomes
Live delivery rate for initiated ART cycles, 2014 18.2% (13,373) Treatment outcomes
Clinical pregnancy rate for ART cycles reaching embryo transfer, 2014 31.6% Treatment outcomes
Live delivery rate for autologous fresh cycles started, 2014 15.3% Treatment outcomes
Live delivery rate for autologous fresh cycles started, excluding freeze-all cycles, 2014 17.7% Treatment outcomes
Live delivery rate for autologous fresh embryo transfers, 2014 23.5% Treatment outcomes
Live delivery rate for autologous thaw cycles started, 2014 23.6% Treatment outcomes
Live delivery rate for autologous thaw embryo transfers, 2014 25.2% Treatment outcomes

Pregnancy and birth outcomes by age, 2014

Measure Value Source
Live delivery rate for autologous fresh embryo transfers, women under 30, 2014 38.7% Age-stratified outcomes
Live delivery rate for autologous thaw embryo transfers, women under 30, 2014 29.5% Age-stratified outcomes
Live delivery rate for autologous fresh embryo transfers, women over 44, 2014 1.2% Age-stratified outcomes
Live delivery rate for autologous thaw embryo transfers, women over 44, 2014 7.9% Age-stratified outcomes

Babies born and multiples, 2014

Measure Value Source
Total babies born following ART treatment, 2014 14,238 Babies born
Liveborn babies following ART treatment, 2014 14,016 Babies born
Full-term singleton babies of normal birthweight as a share of ART births, 2014 78.1% Babies born

Multiple births, five-year trend (2010 to 2014)

Measure Value Source
ART multiple-delivery rate, 2010 to 2014 7.9% to 4.9% Multiple birth trends
Decrease in the ART multiple-delivery rate, 2010 to 2014 38% Multiple birth trends
Single embryo transfer rate, 2010 to 2014 69.6% to 82.9% Multiple birth trends

Live birth rate, five-year trend (2011 to 2014)

Measure Value Source
ART live birth rate per initiated cycle, 2011 to 2014 18.1% to 19.8% Trends

Patient age, 2014

Measure Value Source
Average age of women undergoing autologous ART cycles, 2014 35.8 years Patient age
Share of autologous-cycle women aged 40 or older, 2014 25.5% Patient age

Our summary of the report's published figures, each citing its table, figure or section. The full report is at the publisher's link.

Read the guide

Topics

By this author

Related research

Assisted Reproduction › Registries and Reporting › National Registry Data
DOI 10.26190/unsworks/30470 10.26190/unsworks/30470 Harris et al. 2016, Harris 2016